International expert consensus recommendations on standardised nomenclature of SSA/Ro (TROVE2/Ro60 and TRIM21/Ro52) autoantibodies in autoimmune diseases

Annals of the Rheumatic Diseases · Published 2026-05-01 · DOI 10.1016/j.ard.2026.04.007

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.ard.2026.04.007

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Multiplex microblot array as an integrated approach to ANA screening and antigen-specific profiling in systemic autoimmune rheumatic diseases · Clinical Chemistry and Laboratory Medicine · 2026 · Cites or is cited by this article
Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment · Annals of the Rheumatic Diseases · 2026 · Same journal
Response to correspondence on ‘Final validation of the hierarchical framework for outcomes in axial spondyloarthritis: longitudinal determinants of health-related quality of life’ · Annals of the Rheumatic Diseases · 2026 · Same journal
Mitochondrial-impaired ductal epithelium fuels TLS formation in Sjögren’s disease · Annals of the Rheumatic Diseases · 2026 · Same journal
Development and validation of quality indicators for lupus nephritis, based on the 2025 EULAR recommendations: adherence trends and impact on clinical outcomes · Annals of the Rheumatic Diseases · 2026 · Same journal
Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis · Annals of the Rheumatic Diseases · 2026 · Same journal
Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries · Annals of the Rheumatic Diseases · 2026 · Same journal
Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma · Annals of the Rheumatic Diseases · 2026 · Same journal
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project · Annals of the Rheumatic Diseases · 2026 · Same journal
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis—a case series · Annals of the Rheumatic Diseases · 2026 · Same journal